This panel will explore the different approaches to demarcating the roles of MES and DCS in Biopharma Drug Substance manufacturing. Industry experts will discuss MES-driven versus DCS-driven strategies for orchestrating the production process, including loose versus tight coupling and other key factors to consider for each approach. Find out more about:
- Dividing responsibilities between MES and DCS to optimize production orchestration.
- Trade-offs between loose and tight coupling, and their impact on flexibility, control, and compliance.
- Best practices and real-world strategies for MES/DCS integration in biopharma manufacturing.
&nsbp;
